Tech Company Financing Transactions
SynGen Funding Round
SynGen closed a $5 million Series A investment round on 10/6/2014. Investors included Bay City Capital.
Transaction Overview
Company Name
Announced On
10/6/2014
Transaction Type
Venture Equity
Amount
$5,000,000
Round
Series A
Investors
Bay City Capital (Carl Goldfoscher)
Proceeds Purpose
The latest financing will allow us to make our first sales of the SynGenX�-1000 System to cord blood banks, and to continue to commercialize the SynGenX-Lab and CellWashPRO devices for stem cell processing customers.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
2711 Citrus Rd.
Rancho Cordova, CA 95742
USA
Rancho Cordova, CA 95742
USA
Phone
Website
Email Address
Overview
At SynGen Inc. we develop advanced cell separation tools and accessories, applying innovative design to aid regenerative medicine workflows.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Chris Xu
Chief Technical Officer
Philip Coelho
VP - General Counsel
James Xu
Browse more venture capital transactions:
Prev: 10/6/2014: BuildZoom venture capital transaction
Next: 10/6/2014: Nilas venture capital transaction
Share this article
Where The Data Comes From
We do our best to record every notable VC transaction. VC investment data records reported here are sourced from company press releases and news coverage. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs